Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study of the Effect of Acute Aromatase Inhibition on Breast MRI Postmenopausal Women

NCT01129622 is registered in ClinicalTrials.gov with Mount Sinai Hospital, Canada as lead sponsor.

NCT NCT01129622
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01129622 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study of the Effect of Acute Aromatase Inhibition on Breast MRI Postmenopausal Women
Lead sponsor
Mount Sinai Hospital, Canada
Phase
Phase 2
Overall status
Completed
Start date
October 31, 2008
Completion date
September 30, 2010
Enrollment
16 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer